Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate
(223)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate
(135)
- User Facilities (27)
Researcher
- Ben Lamm
- Beth L Armstrong
- Brian Sanders
- Bruce A Pint
- Derek Splitter
- Gerald Tuskan
- Gurneesh Jatana
- Ilenne Del Valle Kessra
- Isaiah Dishner
- James Szybist
- Jeff Foster
- Jerry Parks
- John F Cahill
- Josh Michener
- Liangyu Qian
- Meghan Lamm
- Paul Abraham
- Shajjad Chowdhury
- Steven J Zinkle
- Tim Graening Seibert
- Tolga Aytug
- Vilmos Kertesz
- Weicheng Zhong
- Wei Tang
- Xiang Chen
- Xiaohan Yang
- Yang Liu
- Yanli Wang
- Ying Yang
- Yutai Kato

Enzymes for synthesis of sequenced oligoamide triads and tetrads that can be polymerized into sequenced copolyamides.
Contact
To learn more about this technology, email partnerships@ornl.gov or call 865-574-1051.

Method to operate a compression ignition engine in dual fuel operation with premixed turbulent flame propagation from low to high loads.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

New demands in electric vehicles have resulted in design changes for the power electronic components such as the capacitor to incur lower volume, higher operating temperatures, and dielectric properties (high dielectric permittivity and high electrical breakdown strengths).

The first wall and blanket of a fusion energy reactor must maintain structural integrity and performance over long operational periods under neutron irradiation and minimize long-lived radioactive waste.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

The invention provides on-line analysis of droplets for mass spectrometry.